Eli Lilly LLY cuts 2024 revenue outlook for weight-loss drugs
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
Novo Nordisk A/S
Eli Lilly CEO Hopes New Weight-Loss Pill Approved Next Year
David Ricks, CEO of Eli Lilly Scott Mlyn | CNBC Eli Lilly It expects its experimental weight-loss pill to be…
High-cost weight-loss drugs drive nutritional counseling to employers
Wegovy, Ozempic and Mounjaro weight loss medication packages. Image Alliance | fake images A few years ago, when Virta Health…
Eli Lilly's lead in the obesity race has increased. Its recent stock performance says otherwise.
Eli Lilly investors have received some very good news in recent months, with one notable exception regarding the stock's performance.…
Medicare May Cover Eli Lilly's Zepbound for Sleep Apnea: Health Department Agency
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Eli Lilly seeks to extend its winning streak in the general market to 6 years
Eli Lilly has outperformed the S&P 500 for five straight years as Wall Street realized its huge opportunity in obesity…
Digital health stocks will get hit by Wall Street in 2024, but Hims will soar
Doximity on the New York Stock Exchange for its IPO, June 24, 2021. Source: New York Stock Exchange If the…
FDA Approves Eli Lilly's Zepbound Weight-Loss Drug for Sleep Apnea
An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York, U.S., on Thursday, March…
Merck signs weight loss pills licensing agreement with Hansoh Pharma
Exterior view of the entrance to Merck headquarters on February 5, 2024 in Rahway, New Jersey. Spencer Platt | fake…
Ozempic faces scrutiny over possible risk of eye condition
A box of Ozempic manufactured by Novo Nordisk is seen in a pharmacy in London, Britain, March 8, 2024. Hollie…